Market News

SEBI is probing seven individuals for allegedly using Telegram, WhatsApp and X to influence retail investors and profit from small-cap stock trades.

The transaction involved a total of 11 domestic and global investors. ICICI Prudential Mutual Fund, Bajaj Finserv, Bandhan Mutual Fund, State Bank of India Edelweiss Mutual Fund were among the major buyers in the block deal.

Key companies in focus include Sun Pharma, NTPC Green Energy, Hindalco Industries, Eicher Motors, Colgate-Palmolive (India), Fortis Healthcare and 3M India.

Traders will not be able to create new positions in these stocks in the F&O segment after the effective date.

In a post on X on Friday, Shenoy outlined that the Central Bank clocked a bottom-line of nearly 4 lakh crore, and even then they chose to keep a substantial portion of it into their Contingent Risk Buffer.

Earlier this week, the financial services arm of Aditya Birla Group announced a Rs 4,000 crore preferential issue of equity shares to the group companies and International Finance Corporation (IFC).

The main Wall Street indices stayed agnostic to global headwinds, as they logged a climb despite oil prices firming up.

Consolidate revenue of Hindalco advanced by 17.5% quarter-on-quarter for the three months ended March.

At the indicated price of Rs 31.01 a share, non-retail investors put in over Rs 2,380 crore worth bids for Central Bank OFS.

NTPC Green Energy's revenue rose 46.7% year-on-year for the March quarter to Rs 912.6 crore, compared to Rs 622.3 crore in the year-ago period.

Revenue growth stays strong in Q4, but higher costs weigh on margins; board announces second interim dividend of Rs 24 per share.

The development is likely to keep Oil India's shares in focus on Monday. The stock closed 0.61% lower at Rs. 500.45 on Friday, as compared to 0.27% uptick in the benchmark Nifty 50.

The overall reserves had jumped by $6.295 billion to $696.988 billion during the week ended May 8.

The dividend is subject to shareholders' approval at the next annual general meeting of the company.

Additionally, the drugmaker has announced plans of raising up to Rs 5,000 crore via qualified institutional placements and otehr modes.

Consolidate revenue of the Royal Enfield maker advanced by 16% year-on-year for the three months ended March, reaching Rs 6,080 crore in comparison to Rs 5,241 crore.

The buyback is expected to completed in the first quarter of fiscal 2027, with the company looking to acquire the shares at Rs 250 per piece.

Forex traders said markets found some comfort after comments from US Secretary of State Marco Rubio hinted that diplomatic talks linked to the Iran situation were moving in a constructive direction.

Sun Pharma registered exceptional gains worth approximately Rs 1,700 crore in fiscal 2026.

Nifty Bank and financial services indices led gains, rising around 0.8% and 0.77%, respectively. On the downside, media, realty and IT indices declined, with media falling the most during trade.